James L Velianou
Overview
Explore the profile of James L Velianou including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
55
Citations
1178
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bainey K, Wood D, Bossard M, Campo G, Cantor W, Lavi S, et al.
Am Heart J
. 2023 Oct;
267:70-80.
PMID: 37871781
Background: In ST-segment elevation myocardial infarction (STEMI), complete revascularization with percutaneous coronary intervention (PCI) reduces major cardiovascular events compared with culprit-lesion-only PCI. Whether age influences these results remains unknown. Methods:...
2.
dEntremont M, Alrashidi S, Alansari O, Brochu B, Heenan L, Skuriat E, et al.
EuroIntervention
. 2023 Mar;
19(1):73-79.
PMID: 36876864
Background: Whether ultrasound (US)-guided femoral access compared to femoral access without US guidance decreases access site complications in patients receiving a vascular closure device (VCD) is unclear. Aims: We aimed...
3.
Mehta S, Pare G, Lonn E, Jolly S, Natarajan M, Pinilla-Echeverri N, et al.
EuroIntervention
. 2022 Nov;
18(11):e888-e896.
PMID: 36349701
Background: In patients with ST-segment elevation myocardial infarction (STEMI), early initiation of high-intensity statin therapy, regardless of low-density lipoprotein (LDL) cholesterol levels, is the standard of practice worldwide. Aims: We...
4.
Butala N, Wood D, Li H, Chinnakondepalli K, Lauck S, Sathananthan J, et al.
Circ Cardiovasc Interv
. 2022 Oct;
15(10):e012168.
PMID: 36256698
Background: The 3M-TAVR trial (3M-Transcatheter Aortic Valve Replacement) demonstrated the feasibility and safety of next-day hospital discharge after transfemoral TAVR with implementation of a minimalist pathway. However, the economic impact...
5.
Jolly S, Alrashidi S, dEntremont M, Alansari O, Brochu B, Heenan L, et al.
JAMA Cardiol
. 2022 Sep;
7(11):1110-1118.
PMID: 36116089
Importance: A significant limitation of femoral artery access for cardiac interventions is the increased risk of vascular complications and bleeding compared with radial access. Strategies to make femoral access safer...
6.
Dehghani P, Cantor W, Wang J, Wood D, Storey R, Mehran R, et al.
Circ Cardiovasc Interv
. 2021 Jul;
14(8):e010458.
PMID: 34320839
[Figure: see text].
7.
Winter J, Healey J, Sheth T, Velianou J, Schwalm J, Smith A, et al.
CJC Open
. 2020 Sep;
2(5):416-419.
PMID: 32995727
Remote ambulatory cardiac monitoring (rACM) could identify high-grade atrioventricular block (AVB) before and after transcatheter aortic valve replacement (TAVR). Retrospective analysis of patients undergoing TAVR, with 14-day rACM before and...
8.
Sheth T, Pinilla-Echeverri N, Moreno R, Wang J, Wood D, Storey R, et al.
J Am Coll Cardiol
. 2020 Sep;
76(11):1277-1286.
PMID: 32912441
Background: In the COMPLETE (Complete vs Culprit-only Revascularization to Treat Multi-vessel Disease After Early PCI for STEMI) trial, angiography-guided percutaneous coronary intervention (PCI) of nonculprit lesions with the aim of...
9.
Lauck S, Arnold S, Borregaard B, Sathananthan J, Humphries K, Baron S, et al.
Cardiovasc Revasc Med
. 2020 Jun;
21(12):1573-1578.
PMID: 32571762
Background: Patients with severe, symptomatic aortic stenosis derive substantial 30-day quality of life (QOL) benefit from transcatheter aortic valve replacement (TAVR). Whether the QOL benefit of TAVR emerges earlier is...
10.
Wood D, Sathananthan J, Gin K, Mansour S, Ly H, Quraishi A, et al.
Can J Cardiol
. 2020 Apr;
36(5):780-783.
PMID: 32299781
The globe is currently in the midst of a COVID-19 pandemic, resulting in significant morbidity and mortality. This pandemic has placed considerable stress on health care resources and providers. This...